BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26265699)

  • 21. Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia.
    Toft N; Birgens H; Abrahamsson J; Griškevičius L; Hallböök H; Heyman M; Klausen TW; Jónsson ÓG; Palk K; Pruunsild K; Quist-Paulsen P; Vaitkeviciene G; Vettenranta K; Asberg A; Helt LR; Frandsen T; Schmiegelow K
    Eur J Haematol; 2016 Feb; 96(2):160-9. PubMed ID: 25867866
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bony morbidity in children treated for acute lymphoblastic leukemia.
    Strauss AJ; Su JT; Dalton VM; Gelber RD; Sallan SE; Silverman LB
    J Clin Oncol; 2001 Jun; 19(12):3066-72. PubMed ID: 11408503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemia.
    Karol SE; Larsen E; Cheng C; Cao X; Yang W; Ramsey LB; Fernandez CA; McCorkle JR; Paugh SW; Autry RJ; Lopez-Lopez E; Diouf B; Jeha S; Pui CH; Raetz EA; Winick NJ; Carroll WL; Hunger SP; Loh ML; Devidas M; Evans WE; Yang JJ; Relling MV
    Leukemia; 2017 Jun; 31(6):1325-1332. PubMed ID: 28096535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Osteonecrosis in children with acute lymphoblastic leukemia: A report from Children's Cancer Hospital Egypt (CCHE).
    Ali N; Gohar S; Zaky I; Elghoneimy A; Youssef S; Sameer G; Yassin D; Salem S; Magdi H; Sidhom I
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27440. PubMed ID: 30183135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia.
    Relling MV; Yang W; Das S; Cook EH; Rosner GL; Neel M; Howard S; Ribeiro R; Sandlund JT; Pui CH; Kaste SC
    J Clin Oncol; 2004 Oct; 22(19):3930-6. PubMed ID: 15459215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic risk factors for glucocorticoid-induced osteonecrosis: a meta-analysis.
    Gong LL; Fang LH; Wang HY; Peng JH; Si K; Zhu J; Han FF; Wang YH; Du GH; Pei LX; Liu LH
    Steroids; 2013 Apr; 78(4):401-8. PubMed ID: 23357434
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemia.
    den Hoed MA; Pluijm SM; te Winkel ML; de Groot-Kruseman HA; Fiocco M; Hoogerbrugge P; Leeuw JA; Bruin MC; van der Sluis IM; Bresters D; Lequin MH; Roos JC; Veerman AJ; Pieters R; van den Heuvel-Eibrink MM
    Haematologica; 2015 Dec; 100(12):1564-70. PubMed ID: 26405155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of ABCB1/MDR1 polymorphisms in patients with glucocorticoid-induced osteonecrosis of the femoral head: Evidence for a meta-analysis.
    Zhou Z; Hua Y; Liu J; Zuo D; Wang H; Chen Q; Zheng L; Cai Z
    Gene; 2015 Sep; 569(1):34-40. PubMed ID: 25791493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia.
    Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008727. PubMed ID: 29106702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia.
    te Winkel ML; Pieters R; Hop WC; de Groot-Kruseman HA; Lequin MH; van der Sluis IM; Bökkerink JP; Leeuw JA; Bruin MC; Egeler RM; Veerman AJ; van den Heuvel-Eibrink MM
    J Clin Oncol; 2011 Nov; 29(31):4143-50. PubMed ID: 21947829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteonecrosis during the treatment of childhood acute lymphoblastic leukemia: a prospective MRI study.
    Ojala AE; Pääkkö E; Lanning FP; Lanning M
    Med Pediatr Oncol; 1999 Jan; 32(1):11-7. PubMed ID: 9917747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Osteonecrosis in children treated for acute lymphoblastic leukemia: a magnetic resonance imaging study after treatment.
    Ojala AE; Lanning FP; Pääkkö E; Lanning BM
    Med Pediatr Oncol; 1997 Oct; 29(4):260-5. PubMed ID: 9251731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between NR3C1 Gene Polymorphisms and Toxicity Induced by Glucocorticoids Therapy in Saudi Children with Acute Lymphoblastic Leukemia.
    El-Fayoumi R; Hagras M; Abozenadaha A; Bawazir W; Shinawi T
    Asian Pac J Cancer Prev; 2018 May; 19(5):1415-1423. PubMed ID: 29802709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteonecrosis as a complication in pediatric patients with acute lymphoblastic leukemia.
    Riccio I; Pota E; Marcarelli M; Affinita MC; Di Pinto D; Indolfi C; Del Regno N; Esposito M
    Pediatr Med Chir; 2016 Nov; 38(3):118. PubMed ID: 28009137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Family-based exome-wide assessment of maternal genetic effects on susceptibility to childhood B-cell acute lymphoblastic leukemia in hispanics.
    Archer NP; Perez-Andreu V; Scheurer ME; Rabin KR; Peckham-Gregory EC; Plon SE; Zabriskie RC; De Alarcon PA; Fernandez KS; Najera CR; Yang JJ; Antillon-Klussmann F; Lupo PJ
    Cancer; 2016 Dec; 122(23):3697-3704. PubMed ID: 27529658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia.
    Mogensen SS; Harila-Saari A; Mäkitie O; Myrberg IH; Niinimäki R; Vestli A; Hafsteinsdottir S; Griškevicius L; Saks K; Hallböök H; Retpen J; Helt LR; Toft N; Schmiegelow K; Frandsen TL;
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27300. PubMed ID: 29943905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Osteonecrosis is unrelated to hip anatomy in children with acute lymphoblastic leukemia.
    Portera MV; Karol SE; Smith C; Yang W; Cheng C; Neel MD; Pui CH; Relling MV; Kaste SC
    Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28035753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence and outcome of osteonecrosis in children and adolescents after intensive therapy for acute lymphoblastic leukemia (ALL).
    Padhye B; Dalla-Pozza L; Little D; Munns C
    Cancer Med; 2016 May; 5(5):960-7. PubMed ID: 26792372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Pharmacogenetic Study of VDR fok1 and TYMS Polymorphisms and Their Association With Glucocorticoid-Induced Osteonecrosis in Egyptian Children With Acute Lymphoblastic Leukemia.
    ElHarouni D; Yassin D; Ali N; Gohar S; Zaky I; Adwan H; Sidhom I
    Front Oncol; 2018; 8():541. PubMed ID: 30533396
    [No Abstract]   [Full Text] [Related]  

  • 40. Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia.
    Diouf B; Crews KR; Lew G; Pei D; Cheng C; Bao J; Zheng JJ; Yang W; Fan Y; Wheeler HE; Wing C; Delaney SM; Komatsu M; Paugh SW; McCorkle JR; Lu X; Winick NJ; Carroll WL; Loh ML; Hunger SP; Devidas M; Pui CH; Dolan ME; Relling MV; Evans WE
    JAMA; 2015 Feb; 313(8):815-23. PubMed ID: 25710658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.